Synchron starts INTENT, a 10-person US early feasibility study of its endovascular BCI

Synchron/Stentrode BCI

Synchron launched INTENT (INdependence Through Endovascular Neuroprosthetic Technology), an early feasibility study of its endovascular brain-computer interface with an estimated start in April 2026 and an estimated 10 participants. The minimally invasive Stentrode implant is delivered via catheter through the jugular vein to the brain's superior sagittal sinus, avoiding open surgery.

• INTENT early feasibility study estimated to start April 2026 with about 10 participants.
• Minimally invasive endovascular approach: Stentrode delivered via catheter through jugular vein to superior sagittal sinus.
• Primary completion estimated June 2027 with overall completion by December 2029.